Your browser doesn't support javascript.
loading
Infrequent ras activation in chronic myelogenous leukemia (CML): activating 61st codon mutation in the CML-derived cell line, IM-9.
Needleman, S W; Gutheil, J C; Kapil, V; Mane, S M.
Affiliation
  • Needleman SW; Department of Medicine, University of Maryland Hospital, University of Maryland Cancer Center, Baltimore.
Leukemia ; 3(11): 827-9, 1989 Nov.
Article in En | MEDLINE | ID: mdl-2682048
ABSTRACT
The proto-oncogene c-N-ras frequently bears point mutations in ANLL cell DNA which endow it with the capacity to transform NIH/3T3 cells in vitro. Chronic myelogenous leukemia (CML) is a neoplasm highly related to ANLL since it involves the same hematopoietic progenitor cells and ultimately transforms to a neoplasm virtually indistinguishable from acute nonlymphoblastic leukemia (ANLL). Thus, we and others have examined ras genes in CML. This report confirms that ras gene activation is a very infrequent event in CML. However, a lymphoblastic cell line derived from a patient with CML did exhibit a novel second exon 61st codon activating mutation of c-N-ras.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Codon / RNA, Messenger / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gene Expression Regulation / Genes, ras / Mutation Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1989 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Codon / RNA, Messenger / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gene Expression Regulation / Genes, ras / Mutation Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1989 Document type: Article